BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 34503213)

  • 1. Therapeutic Potential of Targeting the SUMO Pathway in Cancer.
    Kukkula A; Ojala VK; Mendez LM; Sistonen L; Elenius K; Sundvall M
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ALS-Associated SOD1 Mutant SUMOylation and Aggregation by SENP and PIAS Family Proteins.
    Wada H; Suzuki D; Niikura T
    J Mol Neurosci; 2020 Dec; 70(12):2007-2014. PubMed ID: 32462635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
    Chen S; Dong D; Xin W; Zhou H
    Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer.
    Wu W; Huang C
    Life Sci; 2023 Nov; 332():122085. PubMed ID: 37722589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Dual SENP1 and SENP2 Inhibitor.
    Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.
    Lara-Ureña N; Jafari V; García-Domínguez M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO: From Bench to Bedside.
    Chang HM; Yeh ETH
    Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the development of SUMO specific protease (SENP) inhibitors.
    Kumar A; Zhang KY
    Comput Struct Biotechnol J; 2015; 13():204-11. PubMed ID: 25893082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression.
    Bawa-Khalfe T; Yeh ET
    Genes Cancer; 2010 Jul; 1(7):748-752. PubMed ID: 21152235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ubiquitin-Like SUMO System and Heart Function: From Development to Disease.
    Mendler L; Braun T; Müller S
    Circ Res; 2016 Jan; 118(1):132-44. PubMed ID: 26837744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications.
    Long X; Zhao B; Lu W; Chen X; Yang X; Huang J; Zhang Y; An S; Qin Y; Xing Z; Shen Y; Wu H; Qi Y
    Front Physiol; 2020; 11():558220. PubMed ID: 33192553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SENP Proteases as Potential Targets for Cancer Therapy.
    Tokarz P; Woźniak K
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation.
    Abdel-Hafiz HA; Horwitz KB
    BMC Mol Biol; 2012 Mar; 13():10. PubMed ID: 22439847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.
    Cui W; Sun M; Galeva N; Williams TD; Azuma Y; Staudinger JL
    Drug Metab Dispos; 2015 Sep; 43(9):1316-25. PubMed ID: 26063058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.
    Zhang FL; Yang SY; Liao L; Zhang TM; Zhang YL; Hu SY; Deng L; Huang MY; Andriani L; Ma XY; Shao ZM; Li DQ
    Theranostics; 2023; 13(3):973-990. PubMed ID: 36793866
    [No Abstract]   [Full Text] [Related]  

  • 16. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
    Hua D; Wu X
    Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised annotation and extended characterizations of components of the
    Lin YL; Chung CL; Huang PJ; Chen CH; Fang SC
    Plant Direct; 2020 Sep; 4(9):e00266. PubMed ID: 33015534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function and regulation of ubiquitin-like SUMO system in heart.
    Wang Y; Liu Z; Bian X; Zhao C; Zhang X; Liu X; Wang N
    Front Cell Dev Biol; 2023; 11():1294717. PubMed ID: 38033852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation indirectly suppresses activity of the HIF-1α pathway in intestinal epithelial cells.
    Malkov MI; Flood D; Taylor CT
    J Biol Chem; 2023 Nov; 299(11):105280. PubMed ID: 37742924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.